FindTrial
Sign In

Long-term effect of Autologous serum injection therapy on autoimmune chronic urticaria

Long-term effect of Autologous serum injection therapy on autoimmune chronic urticaria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000925
Enrollment
Unknown
Registered
2010-07-06
Start date
2010-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic urticaria

Interventions

A:oral levocetirizine 5mg/d and normal sodium intramuscular injection in buttocks
B:oral levocetirizine 5mg/d and autologous serum intramuscular injection in buttocks

Sponsors

Division of Scientific Research Affairs, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. chronic spontaneous urticaira; 2. positive autologous serum skin test; 3. male and female aged 18 to 60 years old

Exclusion criteria

Exclusion criteria: 1. other types of chronic urticaria (including physical urticaria, aquagenic urticaria, cholinergic urticaria, contact urticaria, exercise induced urticaria); 2. women in pregnancy and/or lactation; 3. accompanied with severe systemic diseases.

Design outcomes

Primary

MeasureTime frame
DLQI;Patients on the severity of the disease overall grading evaluation;urticaria activity score;—

Secondary

MeasureTime frame
tryptase;IL-4, IL-5, gama-IF;—

Countries

China

Contacts

Public ContactZhiqiang Song
zhiqiang.song@hotmail.com+86 13883112836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026